Anne Lesage, Chief Early Development at Pharvaris N.V. (PHVS), sold 48,300 shares at $30.08 ($1.5M) on 2026-04-29, disclosed to the SEC on 2026-05-01.
Scheduled sale ($1.5M) by Chief Early Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.06 | 3,700 | $111K | 7.6% |
| 2 | $30.08 | 3,700 | $111K | 7.6% |
| 3 | $30.26 | 19,200 | $581K | 39.8% |
| 4 | $30.26 | 3,700 | $112K | 7.7% |
| 5 | $30.26 | 18,000 | $545K | 37.3% |
| Total | $30.23 avg | 48,300 |
| $1.5M |
| 100% |
| Filing → |
| PHVS | SELL | 2026-07-01 | $2.7M | — | Filing → |
| PHVS | SELL | 2026-06-29 | $162K | — | Filing → |
| PHVS | SELL | 2026-04-24 | $439K | — | Filing → |